| Literature DB >> 29660607 |
Yonglong Guo1, Qiaolang Zeng2, Shiwei Liu2, Quan Yu3, Peiyuan Wang2, Hongjie Ma4, Shanshan Shi5, Xin Yan6, Zekai Cui1, Mengyuan Xie7, Yunxia Xue8, Qingbing Zha5, Zhijie Li8, Jun Zhang7, Shibo Tang9, Jiansu Chen10.
Abstract
We have established an induced pluripotent stem (iPS) cell line using urine-derived cells from a 27-year-old male patient with retinitis pigmentosa associated with point mutations in the USH2A gene. Feeder-free culture conditions and the integration-free CytoTune™-iPS 2.0 Sendai Reprogramming Kit were used.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29660607 DOI: 10.1016/j.scr.2018.03.022
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020